Tenon Medical (NASDAQ:TNON) reported quarterly losses of $(0.22) per share which beat the analyst consensus estimate of $(0.36) by 38.89 percent. This is a 77.55 percent increase over losses of $(0.98) per share from the same period last year. The company reported quarterly sales of $1.500 million which beat the analyst consensus estimate of $1.379 million by 8.81 percent. This is a 94.81 percent increase over sales of $770.000 thousand the same period last year.